DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression.

IF 1.4 Q4 ONCOLOGY Journal of Cancer Metastasis and Treatment Pub Date : 2017-01-01 Epub Date: 2017-03-27 DOI:10.20517/2394-4722.2017.03
Wei Wang, Arul M Mani, Zhao-Hui Wu
{"title":"DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression.","authors":"Wei Wang, Arul M Mani, Zhao-Hui Wu","doi":"10.20517/2394-4722.2017.03","DOIUrl":null,"url":null,"abstract":"<p><p>DNA damage is a vital challenge to cell homeostasis. Cellular responses to DNA damage (DDR) play essential roles in maintaining genomic stability and survival, whose failure could lead to detrimental consequences such as cancer development and aging. Nuclear factor-kappa B (NF-κB) is a family of transcription factors that plays critical roles in cellular stress response. Along with p53, NF-κB modulates transactivation of a large number of genes which participate in various cellular processes involved in DDR. Here the authors summarize the recent progress in understanding DNA damage response and NF-κB signaling pathways. This study particularly focuses on DNA damage-induced NF-κB signaling cascade and its physiological and pathological significance in B cell development and cancer therapeutic resistance. The authors also discuss promising strategies for selectively targeting this genotoxic NF-κB signaling aiming to antagonize acquired resistance and resensitize refractory cancer cells to cytotoxic treatments.</p>","PeriodicalId":15167,"journal":{"name":"Journal of Cancer Metastasis and Treatment","volume":"3 ","pages":"45-59"},"PeriodicalIF":1.4000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/f3/nihms866037.PMC5472228.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Metastasis and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20517/2394-4722.2017.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/3/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

DNA damage is a vital challenge to cell homeostasis. Cellular responses to DNA damage (DDR) play essential roles in maintaining genomic stability and survival, whose failure could lead to detrimental consequences such as cancer development and aging. Nuclear factor-kappa B (NF-κB) is a family of transcription factors that plays critical roles in cellular stress response. Along with p53, NF-κB modulates transactivation of a large number of genes which participate in various cellular processes involved in DDR. Here the authors summarize the recent progress in understanding DNA damage response and NF-κB signaling pathways. This study particularly focuses on DNA damage-induced NF-κB signaling cascade and its physiological and pathological significance in B cell development and cancer therapeutic resistance. The authors also discuss promising strategies for selectively targeting this genotoxic NF-κB signaling aiming to antagonize acquired resistance and resensitize refractory cancer cells to cytotoxic treatments.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
DNA 损伤诱导的核因子-kappa B 激活及其在癌症进展中的作用。
DNA 损伤是对细胞平衡的重要挑战。细胞对DNA损伤的反应(DDR)在维持基因组稳定性和存活方面发挥着至关重要的作用,其失效可能导致癌症发展和衰老等有害后果。核因子-kappa B(NF-κB)是一个转录因子家族,在细胞应激反应中发挥着关键作用。NF-κB 与 p53 一起调节大量基因的转录活化,这些基因参与了 DDR 所涉及的各种细胞过程。在此,作者总结了最近在了解 DNA 损伤应答和 NF-κB 信号通路方面取得的进展。本研究特别关注 DNA 损伤诱导的 NF-κB 信号级联及其在 B 细胞发育和癌症治疗耐药性中的生理和病理意义。作者还讨论了选择性靶向这种基因毒性NF-κB信号转导的前景广阔的策略,旨在拮抗获得性抗性,使难治性癌细胞对细胞毒治疗重新敏感。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.20
自引率
5.30%
发文量
460
期刊最新文献
Thermal ablation of metastatic disease to the musculoskeletal system Does delaying surgery following induction chemotherapy compromise survival in patients with mesothelioma? Advanced breast cancer metastasized in the brain: treatment standards and innovations. Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma? An update on clinical trials for chemoprevention of human skin cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1